IL148220A0 - Pharmaceutical preparation containing nanosol - Google Patents

Pharmaceutical preparation containing nanosol

Info

Publication number: IL148220A0
Authority: IL; Israel
Prior art keywords: pharmaceutical preparation; preparation containing; nanosol; containing nanosol; pharmaceutical
Prior art date: 1999-08-27

Application number

IL14822000A

Original Assignee

Lohmann Therapie Syst Lts

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-27

Filing date

2000-08-14

Publication date

2002-09-12

2000-08-14 Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts

2002-09-12 Publication of IL148220A0 publication Critical patent/IL148220A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0004—Preparation of sols
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0004—Preparation of sols
- B01J13/0039—Post treatment
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Dispersion Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Nanotechnology (AREA)
Optics & Photonics (AREA)
Physics & Mathematics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IL14822000A 1999-08-27 2000-08-14 Pharmaceutical preparation containing nanosol IL148220A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19940794A DE19940794A1 (en)	1999-08-27	1999-08-27	Pharmaceutical preparation
PCT/EP2000/007904 WO2001015669A1 (en)	1999-08-27	2000-08-14	Pharmaceutical preparation containing nanosol

Publications (1)

Publication Number	Publication Date
IL148220A0 true IL148220A0 (en)	2002-09-12

Family

ID=7919871

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14822000A IL148220A0 (en)	1999-08-27	2000-08-14	Pharmaceutical preparation containing nanosol
IL148220A IL148220A (en)	1999-08-27	2002-02-18	Pharmaceutical preparation containing nanosol

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL148220A IL148220A (en)	1999-08-27	2002-02-18	Pharmaceutical preparation containing nanosol

Country Status (25)

Country	Link
EP (1)	EP1206253B1 (en)
JP (1)	JP2003508423A (en)
KR (1)	KR100624499B1 (en)
CN (1)	CN1181815C (en)
AR (1)	AR025392A1 (en)
AT (1)	ATE279180T1 (en)
AU (1)	AU779692B2 (en)
BR (1)	BR0013563A (en)
CA (1)	CA2382359C (en)
CZ (1)	CZ301704B6 (en)
DE (2)	DE19940794A1 (en)
DK (1)	DK1206253T3 (en)
ES (1)	ES2231265T3 (en)
HK (1)	HK1047037B (en)
HU (1)	HU227609B1 (en)
IL (2)	IL148220A0 (en)
MX (1)	MXPA02002048A (en)
NZ (1)	NZ517541A (en)
PL (1)	PL203860B1 (en)
PT (1)	PT1206253E (en)
RU (1)	RU2256440C2 (en)
TR (1)	TR200200520T2 (en)
TW (1)	TWI267384B (en)
WO (1)	WO2001015669A1 (en)
ZA (1)	ZA200201135B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100638041B1 (en) *	2003-12-24	2006-10-23	주식회사 삼양사	A nanoparticle composition of a water-soluble drug for oral administration and a preparation method thereof
KR100767336B1 (en) *	2006-04-19	2007-10-18	서평원	Chitin/chitosan based functional organic-inorganic composite material and method for producing the same and use thereof
US9161901B2 (en)	2008-02-21	2015-10-20	University Of South Florida	Nanoparticle targeted drug delivery to the lungs using extra-testicular Sertoli cells
UA90013C2 (en)	2008-03-19	2010-03-25	Давид Анатолійович Нога	Pharmaceutical composition containing insulin and process for the preparation thereof
PL220269B1 (en)	2008-04-21	2015-09-30	Przedsiębiorstwo Produkcji Farmaceutycznej Hasco Lek Spółka Akcyjna	Composite carrier of powdered medicines, method of production the medicine carrier and equipment for production of particles of composite carrier
DE102009024542A1 (en) *	2009-06-10	2010-12-16	Arivine Pharma Ag	Compositions based on chitosan oligosaccharides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5474989A (en) *	1988-11-11	1995-12-12	Kurita Water Industries, Ltd.	Drug composition
DE4140195C2 (en) *	1991-12-05	1994-10-27	Alfatec Pharma Gmbh	Pharmaceutical nanosol and process for its manufacture
US6184037B1 (en) *	1996-05-17	2001-02-06	Genemedicine, Inc.	Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
CA2228251A1 (en) *	1996-06-11	1997-12-18	Zonagen, Inc.	Chitosan drug delivery system
ES2114502B1 (en) *	1996-07-29	1999-07-01	Univ Santiago Compostela	APPLICATION OF NANOPARTICLES BASED ON HYDROPHILIC POLYMERS AS PHARMACEUTICAL FORMS.
DE19845246A1 (en) *	1997-12-18	1999-06-24	Henkel Kgaa	Vitamin E compositions
CA2318493A1 (en) *	1998-01-16	1999-07-22	The Johns Hopkins University	Oral delivery of nucleic acid vaccines by particulate complexes

1999
- 1999-08-27 DE DE19940794A patent/DE19940794A1/en not_active Withdrawn
2000
- 2000-08-14 IL IL14822000A patent/IL148220A0/en unknown
- 2000-08-14 JP JP2001519883A patent/JP2003508423A/en not_active Withdrawn
- 2000-08-14 HU HU0300345A patent/HU227609B1/en not_active IP Right Cessation
- 2000-08-14 DK DK00964016T patent/DK1206253T3/en active
- 2000-08-14 PL PL354572A patent/PL203860B1/en not_active IP Right Cessation
- 2000-08-14 RU RU2002103512/15A patent/RU2256440C2/en not_active IP Right Cessation
- 2000-08-14 CZ CZ20020653A patent/CZ301704B6/en not_active IP Right Cessation
- 2000-08-14 BR BR0013563-1A patent/BR0013563A/en not_active IP Right Cessation
- 2000-08-14 PT PT00964016T patent/PT1206253E/en unknown
- 2000-08-14 AT AT00964016T patent/ATE279180T1/en active
- 2000-08-14 WO PCT/EP2000/007904 patent/WO2001015669A1/en active IP Right Grant
- 2000-08-14 AU AU75094/00A patent/AU779692B2/en not_active Ceased
- 2000-08-14 TR TR2002/00520T patent/TR200200520T2/en unknown
- 2000-08-14 NZ NZ517541A patent/NZ517541A/en not_active IP Right Cessation
- 2000-08-14 MX MXPA02002048A patent/MXPA02002048A/en unknown
- 2000-08-14 KR KR1020027002507A patent/KR100624499B1/en not_active IP Right Cessation
- 2000-08-14 ES ES00964016T patent/ES2231265T3/en not_active Expired - Lifetime
- 2000-08-14 EP EP00964016A patent/EP1206253B1/en not_active Expired - Lifetime
- 2000-08-14 CA CA002382359A patent/CA2382359C/en not_active Expired - Fee Related
- 2000-08-14 CN CNB008119031A patent/CN1181815C/en not_active Expired - Fee Related
- 2000-08-14 DE DE2000508259 patent/DE50008259D1/en not_active Expired - Lifetime
- 2000-08-25 AR ARP000104416A patent/AR025392A1/en not_active Application Discontinuation
- 2000-08-25 TW TW089117149A patent/TWI267384B/en not_active IP Right Cessation
2002
- 2002-02-11 ZA ZA200201135A patent/ZA200201135B/en unknown
- 2002-02-18 IL IL148220A patent/IL148220A/en not_active IP Right Cessation
- 2002-11-22 HK HK02108480.8A patent/HK1047037B/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL203860B1 (en)	2009-11-30
CZ2002653A3 (en)	2002-05-15
DE50008259D1 (en)	2004-11-18
DK1206253T3 (en)	2005-01-31
CA2382359A1 (en)	2001-03-08
CA2382359C (en)	2008-03-18
KR20020031416A (en)	2002-05-01
WO2001015669A1 (en)	2001-03-08
CN1181815C (en)	2004-12-29
NZ517541A (en)	2002-08-28
PT1206253E (en)	2005-02-28
HU227609B1 (en)	2011-09-28
CN1370065A (en)	2002-09-18
MXPA02002048A (en)	2002-08-20
JP2003508423A (en)	2003-03-04
AU7509400A (en)	2001-03-26
BR0013563A (en)	2002-07-09
HK1047037A1 (en)	2003-02-07
HUP0300345A2 (en)	2003-09-29
TWI267384B (en)	2006-12-01
TR200200520T2 (en)	2002-06-21
ZA200201135B (en)	2002-08-28
KR100624499B1 (en)	2006-09-18
EP1206253B1 (en)	2004-10-13
PL354572A1 (en)	2004-01-26
AR025392A1 (en)	2002-11-27
IL148220A (en)	2009-05-04
HUP0300345A3 (en)	2009-01-28
DE19940794A1 (en)	2001-03-01
RU2256440C2 (en)	2005-07-20
HK1047037B (en)	2005-03-24
AU779692B2 (en)	2005-02-03
CZ301704B6 (en)	2010-06-02
ES2231265T3 (en)	2005-05-16
EP1206253A1 (en)	2002-05-22
ATE279180T1 (en)	2004-10-15

Publication	Publication Date	Title
CZ20011518A3 (en)	2002-04-17	Pharmaceutical preparation
CZ20011186A3 (en)	2001-09-12	Stabilized pharmaceutical preparation
HK1045650B (en)	2005-04-08	Pharmaceutical composition
PL351686A1 (en)	2003-06-02	Novel pharmaceutical
HUP0203585A3 (en)	2005-01-28	Pharmaceutical combinations
HUP0000137A3 (en)	2001-03-28	Controller-release pharmaceutical composition containing anangetics
IL145632A0 (en)	2002-06-30	Pharmaceutical compounds
EG23937A (en)	2008-01-14	Novel pharmaceutical
GB9916434D0 (en)	1999-09-15	Pharmaceutical compounds
HK1046140A1 (en)	2002-12-27	Solid pharmaceutical preparation
HK1045102A1 (en)	2002-11-15	Pharmaceutical formulations
GB9914255D0 (en)	1999-08-18	Pharmaceutical compounds
PL351135A1 (en)	2003-03-24	Novel pharmaceutical
HUP0300345A3 (en)	2009-01-28	Pharmaceutical preparation containing nanosol
GB9903784D0 (en)	1999-04-14	Pharmaceutical compounds
IL146341A0 (en)	2002-07-25	Pharmaceutical complex
EG23946A (en)	2008-01-22	Novel pharmaceutical
GB2373499B (en)	2004-11-17	Pharmaceutical compounds
GB9930578D0 (en)	2000-02-16	Pharmaceutical formulations
GB9906126D0 (en)	1999-05-12	Pharmaceutical formulations
GB9923933D0 (en)	1999-12-08	Novel pharmaceutical
GB9923934D0 (en)	1999-12-08	Novel pharmaceutical
HU9902398D0 (en)	1999-10-28	Pharmaceutical preparation
GB9926434D0 (en)	2000-01-12	Pharmaceutical
GB9926437D0 (en)	2000-01-12	Pharmaceutical